FI944513A - Substituoituja fenyylikarbamaatteja ja fenyyliureoita, niiden valmistus ja niiden käyttö 5-HT-antagonisteina - Google Patents

Substituoituja fenyylikarbamaatteja ja fenyyliureoita, niiden valmistus ja niiden käyttö 5-HT-antagonisteina Download PDF

Info

Publication number
FI944513A
FI944513A FI944513A FI944513A FI944513A FI 944513 A FI944513 A FI 944513A FI 944513 A FI944513 A FI 944513A FI 944513 A FI944513 A FI 944513A FI 944513 A FI944513 A FI 944513A
Authority
FI
Finland
Prior art keywords
preparation
substituted
phenylurea
antagonists
ch2c2
Prior art date
Application number
FI944513A
Other languages
English (en)
Swedish (sv)
Other versions
FI944513A0 (fi
Inventor
Alexander William Oxford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Priority claimed from GB929221718A external-priority patent/GB9221718D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI944513A0 publication Critical patent/FI944513A0/fi
Publication of FI944513A publication Critical patent/FI944513A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FI944513A 1992-03-31 1994-09-29 Substituoituja fenyylikarbamaatteja ja fenyyliureoita, niiden valmistus ja niiden käyttö 5-HT-antagonisteina FI944513A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds
GB929221718A GB9221718D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/000779 WO1993020071A1 (en) 1992-03-31 1993-03-26 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists

Publications (2)

Publication Number Publication Date
FI944513A0 FI944513A0 (fi) 1994-09-29
FI944513A true FI944513A (fi) 1994-11-29

Family

ID=27266122

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944513A FI944513A (fi) 1992-03-31 1994-09-29 Substituoituja fenyylikarbamaatteja ja fenyyliureoita, niiden valmistus ja niiden käyttö 5-HT-antagonisteina

Country Status (17)

Country Link
EP (2) EP0640081B1 (fi)
JP (1) JP3236298B2 (fi)
AT (1) ATE188697T1 (fi)
AU (1) AU663780B2 (fi)
CA (1) CA2133083A1 (fi)
CZ (1) CZ236894A3 (fi)
DE (1) DE69327583T2 (fi)
DK (1) DK0640081T3 (fi)
ES (1) ES2141763T3 (fi)
FI (1) FI944513A (fi)
GR (1) GR3032877T3 (fi)
HU (1) HUT72321A (fi)
NO (1) NO943631L (fi)
NZ (1) NZ251687A (fi)
PT (1) PT640081E (fi)
SK (1) SK116394A3 (fi)
WO (1) WO1993020071A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2182568A1 (en) * 1994-02-10 1995-08-17 Makoto Takeuchi Novel carbamate derivative and medicinal composition containing the same
FR2750991A1 (fr) * 1996-07-12 1998-01-16 Pf Medicament Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
FR2752732B1 (fr) 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
CA2392028C (en) 1999-12-07 2009-08-18 Theravance, Inc. Carbamate derivatives having muscarinic receptor antagonist activity
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
IL154279A0 (en) * 2000-08-07 2003-09-17 Glaxosmithkline Lab Sas Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
WO2002018335A1 (fr) * 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Derives d'amine cyclique
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
FR2843750B1 (fr) * 2002-08-23 2004-10-22 Cerep Composes derives d'arylcarbamates, preparation et utilisations
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
JP2008510015A (ja) 2004-08-16 2008-04-03 セラヴァンス, インコーポレーテッド β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
US7528253B2 (en) 2004-08-16 2009-05-05 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
CN102284761B (zh) * 2010-06-17 2014-05-28 纬创资通股份有限公司 电子元件解焊方法以及导热模块

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA76475B (en) * 1975-03-10 1977-08-31 Ciba Geigy Ag Indolyalkylpiperidines
JPH0140026B2 (fi) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
PT640081E (pt) 2000-05-31
FI944513A0 (fi) 1994-09-29
EP0640081A1 (en) 1995-03-01
DE69327583D1 (de) 2000-02-17
HUT72321A (en) 1996-04-29
GR3032877T3 (en) 2000-07-31
JPH07505868A (ja) 1995-06-29
DK0640081T3 (da) 2000-06-19
ES2141763T3 (es) 2000-04-01
NO943631L (no) 1994-11-29
ATE188697T1 (de) 2000-01-15
CA2133083A1 (en) 1993-10-14
EP0972773A1 (en) 2000-01-19
NZ251687A (en) 1995-12-21
JP3236298B2 (ja) 2001-12-10
EP0640081B1 (en) 2000-01-12
DE69327583T2 (de) 2000-05-31
NO943631D0 (no) 1994-09-29
CZ236894A3 (en) 1995-09-13
HU9402825D0 (en) 1994-12-28
AU663780B2 (en) 1995-10-19
WO1993020071A1 (en) 1993-10-14
AU3949793A (en) 1993-11-08
SK116394A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
FI944513A0 (fi) Substituoituja fenyylikarbamaatteja ja fenyyliureoita, niiden valmistus ja niiden käyttö 5-HT-antagonisteina
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
ES8205764A1 (es) Un procedimiento para la preparacion de ureas e isoureas, utiles como herbicidas y como reguladores del crecimiento delas plantas.
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
DK1424330T3 (da) Aktivator for peroxisom proliferator-responsiv receptor delta
DE3851179T2 (de) Oxetanocin.
KR960703402A (ko) 아실화 아미노페닐우레아화합물, 그의 제조 방법 및 제초제 및 식물성장 조절제로서의 그의 용도(acylated aminophenyl urea compounds, their preparation and their use as herbicides and plant-growth regulators)
GR3006746T3 (fi)
ES2037768T3 (es) Procedimiento para preparar n-(fenil(2,6-disustituido))-ureas y carbamatos inhibidores de acil-coa: colesterol acil-transferasa.
DE69028610D1 (de) Chirale 1,5-diiodo-2-methoxy oder benzyloxy Zwischenprodukte
ES8402566A1 (es) Procedimiento para preparar fenilsulfonilisocianatos sustituidos.
DE69228434D1 (de) Verfahren zur Herstellung von Urethangruppen enthaltende Bisoxazolidinen
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
IL71361A (en) 3-(pyrimidin-5-yl-oxyphenyl)-1-benzoyl(thio)ureas,processes for their preparation and pesticidal compositions containing them
SE8501988L (sv) Iminotiazolidinderivat
GB1465226A (en) N-phenylcarbamates
EP0269386A3 (en) Thiophenesulfonamide herbicides
ES2132748T3 (es) Herbicidas de carbamato.
ES8406073A1 (es) Un procedimiento para la preparacion de nuevas benzamidas.
GB1488274A (en) Butynyl carbamates
DE69303352T2 (de) Verfahren zur Herstellung 5-Pyrazolomerkaptan-Derivate und dessen zwischenprodukte
ES8704912A1 (es) Procedimiento para la obtencion de n-(3-cloro-1,2,4-oxadia- zol-5-il)-ureas
DK0661275T3 (da) 1-( alfa-Cyclopropyl-alfa-(substitueret oxy)-otolyl sulfamoyl) -3-(4,6-dimethoxy-2-pyrimidinyl) urinstoffer som herbicide midler.
ES528210A0 (es) Un procedimiento para sintetizar oxanosina